Given that some immunotherapies have provided complete remissions in malignant melanoma (32), we also showed that MGST1-depleted dorsal melanoma had enhanced chemokine production, with concomitantly increased attraction of CD8+ T cell and dendritic cells and decreased tumor growth. This evidence concerns the gene CD8A and melanoma.